TriSalus Life Sciences
TriSalus Life Sciences, Inc.
TriSalus Life Sciences is an oncology-focused medical technology company dedicated to transforming outcomes for patients with solid tumors. By developing and commercializing innovative drug delivery technology, particularly for difficult-to-treat liver and pancreatic tumors, TriSalus strives to enhance therapeutic effectiveness and overcome barriers in cancer treatment.
Products & Team
Pressure-Enabled Drug Delivery™ (PEDD™) Technology
This proprietary technology uses modulated pressure and flow to effectively penetrate solid tumors, improving therapeutic delivery while minimizing exposure to surrounding healthy tissues.
PEDD™ technology resolves the challenge of ineffective drug delivery in solid tumors, significantly improving treatment success rates.
Patients experience challenges with ineffective treatment options and the immunosuppressive environment of tumors that negate effective therapies.